138 related articles for article (PubMed ID: 38141770)
1. Actin-binding protein profilin1 is an important determinant of cellular phosphoinositide control.
Ricci MMC; Orenberg A; Ohayon L; Gau D; Wills RC; Bae Y; Das T; Koes D; Hammond GRV; Roy P
J Biol Chem; 2024 Jan; 300(1):105583. PubMed ID: 38141770
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of SH2-containing inositol phosphatase 2 results in negative regulation of insulin-induced metabolic actions in 3T3-L1 adipocytes via its 5'-phosphatase catalytic activity.
Wada T; Sasaoka T; Funaki M; Hori H; Murakami S; Ishiki M; Haruta T; Asano T; Ogawa W; Ishihara H; Kobayashi M
Mol Cell Biol; 2001 Mar; 21(5):1633-46. PubMed ID: 11238900
[TBL] [Abstract][Full Text] [Related]
3. Profilin-1 downregulation has contrasting effects on early vs late steps of breast cancer metastasis.
Ding Z; Joy M; Bhargava R; Gunsaulus M; Lakshman N; Miron-Mendoza M; Petroll M; Condeelis J; Wells A; Roy P
Oncogene; 2014 Apr; 33(16):2065-74. PubMed ID: 23686314
[TBL] [Abstract][Full Text] [Related]
4. SHIP2 controls plasma membrane PI(4,5)P2 thereby participating in the control of cell migration in 1321 N1 glioblastoma cells.
Elong Edimo W; Ghosh S; Derua R; Janssens V; Waelkens E; Vanderwinden JM; Robe P; Erneux C
J Cell Sci; 2016 Mar; 129(6):1101-14. PubMed ID: 26826186
[TBL] [Abstract][Full Text] [Related]
5. Lipid products of phosphoinositide 3-kinase bind human profilin with high affinity.
Lu PJ; Shieh WR; Rhee SG; Yin HL; Chen CS
Biochemistry; 1996 Nov; 35(44):14027-34. PubMed ID: 8909300
[TBL] [Abstract][Full Text] [Related]
6. SH2-containing inositol phosphatase 2 predominantly regulates Akt2, and not Akt1, phosphorylation at the plasma membrane in response to insulin in 3T3-L1 adipocytes.
Sasaoka T; Wada T; Fukui K; Murakami S; Ishihara H; Suzuki R; Tobe K; Kadowaki T; Kobayashi M
J Biol Chem; 2004 Apr; 279(15):14835-43. PubMed ID: 14744864
[TBL] [Abstract][Full Text] [Related]
7. IRTKS Promotes Insulin Signaling Transduction through Inhibiting SHIP2 Phosphatase Activity.
Wu C; Cui X; Huang L; Shang X; Wu B; Wang N; He K; Han Z
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31212584
[TBL] [Abstract][Full Text] [Related]
8. IRSp53 is a novel interactor of SHIP2: A role of the actin binding protein Mena in their cellular localization in breast cancer cells.
Antoine M; Vandenbroere I; Ghosh S; Erneux C; Pirson I
Cell Signal; 2020 Sep; 73():109692. PubMed ID: 32535200
[TBL] [Abstract][Full Text] [Related]
9. The VASP-profilin1 (Pfn1) interaction is critical for efficient cell migration and is regulated by cell-substrate adhesion in a PKA-dependent manner.
Gau D; Veon W; Shroff SG; Roy P
J Biol Chem; 2019 Apr; 294(17):6972-6985. PubMed ID: 30814249
[TBL] [Abstract][Full Text] [Related]
10. A new layer of phosphoinositide-mediated allosteric regulation uncovered for SHIP2.
Le Coq J; López Navajas P; Rodrigo Martin B; Alfonso C; Lietha D
FASEB J; 2021 Aug; 35(8):e21815. PubMed ID: 34314064
[TBL] [Abstract][Full Text] [Related]
11. SH2-containing inositol phosphatase 2 negatively regulates insulin-induced glycogen synthesis in L6 myotubes.
Sasaoka T; Hori H; Wada T; Ishiki M; Haruta T; Ishihara H; Kobayashi M
Diabetologia; 2001 Oct; 44(10):1258-67. PubMed ID: 11692174
[TBL] [Abstract][Full Text] [Related]
12. SHIP2 inhibition alters redox-induced PI3K/AKT and MAP kinase pathways via PTEN over-activation in cervical cancer cells.
Azzi A
FEBS Open Bio; 2020 Oct; 10(10):2191-2205. PubMed ID: 32881386
[TBL] [Abstract][Full Text] [Related]
13. Phosphoinositide 5-phosphatases SKIP and SHIP2 in ruffles, the endoplasmic reticulum and the nucleus: An update.
Ramos AR; Ghosh S; Suhel T; Chevalier C; Obeng EO; Fafilek B; Krejci P; Beck B; Erneux C
Adv Biol Regul; 2020 Jan; 75():100660. PubMed ID: 31628071
[TBL] [Abstract][Full Text] [Related]
14. Phosphoinositide 5-phosphatase activities control cell motility in glioblastoma: Two phosphoinositides PI(4,5)P2 and PI(3,4)P2 are involved.
Ramos AR; Elong Edimo W; Erneux C
Adv Biol Regul; 2018 Jan; 67():40-48. PubMed ID: 28916189
[TBL] [Abstract][Full Text] [Related]
15. The SH2 domain containing inositol polyphosphate 5-phosphatase-2: SHIP2.
Dyson JM; Kong AM; Wiradjaja F; Astle MV; Gurung R; Mitchell CA
Int J Biochem Cell Biol; 2005 Nov; 37(11):2260-5. PubMed ID: 15964236
[TBL] [Abstract][Full Text] [Related]
16. Actin-binding protein profilin1 promotes aggressiveness of clear-cell renal cell carcinoma cells.
Allen A; Gau D; Francoeur P; Sturm J; Wang Y; Martin R; Maranchie J; Duensing A; Kaczorowski A; Duensing S; Wu L; Lotze MT; Koes D; Storkus WJ; Roy P
J Biol Chem; 2020 Nov; 295(46):15636-15649. PubMed ID: 32883810
[TBL] [Abstract][Full Text] [Related]
17. Imatinib mesilate-induced phosphatidylinositol 3-kinase signalling and improved survival in insulin-producing cells: role of Src homology 2-containing inositol 5'-phosphatase interaction with c-Abl.
Mokhtari D; Al-Amin A; Turpaev K; Li T; Idevall-Hagren O; Li J; Wuttke A; Fred RG; Ravassard P; Scharfmann R; Tengholm A; Welsh N
Diabetologia; 2013 Jun; 56(6):1327-38. PubMed ID: 23462796
[TBL] [Abstract][Full Text] [Related]
18. Regulation of endogenous SH2 domain-containing inositol 5-phosphatase (SHIP2) in 3T3-L1 and human preadipocytes.
Gagnon A; Artemenko Y; Crapper T; Sorisky A
J Cell Physiol; 2003 Nov; 197(2):243-50. PubMed ID: 14502564
[TBL] [Abstract][Full Text] [Related]
19. Silencer of death domains (SODD) inhibits skeletal muscle and kidney enriched inositol 5-phosphatase (SKIP) and regulates phosphoinositide 3-kinase (PI3K)/Akt signaling to the actin cytoskeleton.
Rahman P; Huysmans RD; Wiradjaja F; Gurung R; Ooms LM; Sheffield DA; Dyson JM; Layton MJ; Sriratana A; Takada H; Tiganis T; Mitchell CA
J Biol Chem; 2011 Aug; 286(34):29758-70. PubMed ID: 21712384
[TBL] [Abstract][Full Text] [Related]
20. A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells.
Wisniewski D; Strife A; Swendeman S; Erdjument-Bromage H; Geromanos S; Kavanaugh WM; Tempst P; Clarkson B
Blood; 1999 Apr; 93(8):2707-20. PubMed ID: 10194451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]